Important note

This AI stock analysis for Johnson & Johnson is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Johnson & Johnson - AI Stock Analysis

Analysis generated October 4, 2024

Johnson & Johnson (NYSE: JNJ) is a globally diversified healthcare company engaged in the research, development, manufacture, and sale of a broad range of products in the health care field. It operates through three main segments: Consumer Health, Pharmaceutical, and Medical Devices. Johnson & Johnson has consistently been recognized for its strong ethical standards and commitment to innovation, making it a staple in many investment portfolios.

Fundamental Analysis

For the most recent quarter, Johnson & Johnson reported revenues of $22.4 billion. This represents an increase of 5.74% from the previous quarter, signaling positive short-term growth. However, a decrease of 10.87% compared to the same quarter last year is a potential red flag that may warrant further scrutiny.

The company reported a net income of $4.69 billion for the last quarter, marking a robust 43.96% increase compared to the prior quarter. However, on a year-over-year basis, net income saw an 8.90% decline, which raises some concerns about long-term profitability.

EBITDA came in at $6.47 billion, up 30.21% quarter-over-quarter but down 22.12% year-over-year. This mixed performance suggests the need for careful monitoring.

Johnson & Johnson's current P/E ratio is 24.38, which appears to be within a normal range for the industry, indicating that the stock is reasonably valued.

Technical Analysis

The current stock price of Johnson & Johnson is $160.50. Over the last month, the stock has decreased by 4.10%, indicating short-term bearish sentiment. However, compared to a year ago, the stock price has increased by 5.38%, reflecting a positive long-term trend.

The current SMA10 (Simple Moving Average for 10 days) is 161.24, down slightly from the previous SMA10 of 161.47. This suggests a potential downward trend in price movement.

The RSI (Relative Strength Index) is 26.7, which indicates that the stock might be oversold, pointing to a possible bullish condition.

Alternative Data Analysis

According to data from popular job boards, Johnson & Johnson has 2,000 open positions, a 15% decrease over the last couple of months. This suggests the company might be focusing on improving margins or cutting costs, which is not necessarily a sign of growth.

The business outlook among employees at Johnson & Johnson appears neutral, according to recent sentiment data.

On the customer acquisition front, Johnson & Johnson's website has seen approximately 2.6 million visitors, an 18% increase in the last couple of months. This uptick is a bullish signal, as it could indicate a rise in customer interest and engagement.

In terms of social media presence, Johnson & Johnson has 95,000 followers on Instagram, up 4% in the last couple of months, showing increased interest in the company. However, the company has 250,000 followers on Twitter, and this number has remained flat, indicating a lack of growth in this area.

According to AltIndex’s AI score, which integrates fundamental, technical, and alternative data, Johnson & Johnson has an AI score of 54, signaling a hold recommendation.

Conclusion and Recommendation

Johnson & Johnson presents a mixed picture for potential investors. On the one hand, the company shows positive short-term growth in revenues, net income, and EBITDA. On the other hand, declines compared to the same period last year are concerning and merit close monitoring.

The technical analysis reveals a short-term bearish trend, although the RSI suggests a potential bullish reversal could be on the horizon. The decrease in the number of open job positions signals potential cost-saving measures, while the increase in website traffic and steady growth on Instagram are positive signs for customer engagement.

Considering all the data, including the AltIndex AI score of 54, we recommend a cautious "Hold" on Johnson & Johnson. Investors should closely monitor upcoming financial reports and market conditions to make further investment decisions.

Disclaimer: This AI stock analysis, generated by an experimental AI tool, is for informational purposes only and not financial advice. Information is based on publicly available data and may not always be accurate or current.